Ku80 as a Novel Receptor for Thymosin β4 That Mediates Its Intracellular Activity Different from G-actin Sequestering

Radosław Bednarek, Joanna Boncela, Katarzyna Smolarczyk, Aleksandra Cierniewska‐Cieslak, Elżbieta Wyroba, Czesław S. Cierniewski

Journal of Biological Chemistry · 2007 · 37 citations · 51 references

DOIFull text

Open access

Concepts

Abstract

Our data demonstrate that increased intracellular expression of thymosin β4(Tβ4) is necessary and sufficient to induce plasminogen activator inhibitor type 1 (PAI-1) gene expression in endothelial cells. To describe the mechanism of this effect, we produced Tβ4 mutants with impaired functional motifs and tested their intracellular location and activity. Cytoplasmic distributions of Tβ4(AcSDKPT/4A), Tβ4(KLKKTET/7A), and Tβ4(K16A) mutants fused with green fluorescent protein did not differ significantly from those of wild-type Tβ4. Overexpression of Tβ4, Tβ4(AcSDKPT/4A), and Tβ4(K16A) affected intracellular formation of actin filaments. As expected, Tβ4(K16A) uptake by nuclei was impaired. On the other hand, overexpression of Tβ4(KLKKTET/7A) resulted in developing the actin filament network typical of adhering cells, indicating that the mutant lacked the actin binding site. The mechanism by which intracellular Tβ4 induced the PAI-1 gene did not depend upon the N-terminal tetrapeptide AcSDKP and depended only partially on its ability to bind G-actin or enter the nucleus. Both Tβ4 and Tβ4(AcSDKPT/4A) induced the PAI-1 gene to the same extent, whereas mutants Tβ4(KLKKTET/7A) and Tβ4(K16A) retained about 60% of the original activity. By proteomic analysis, the Ku80 subunit of ATP-dependent DNA helicase II was found to be associated with Tβ4. Ku80 and Tβ4 consistently co-immunoprecipitated in a complex from endothelial cells. Co-transfection of endothelial cells with the Ku80 deletion mutants and Tβ4 showed that the C-terminal arm domain of Ku80 is directly involved in this interaction. Furthermore, down-regulation of Ku80 by specific short interference RNA resulted in dramatic reduction in PAI-1 expression at the level of both mRNA and protein synthesis. These data suggest that Ku80 functions as a novel receptor for Tβ4 and mediates its intracellular activity. Our data demonstrate that increased intracellular expression of thymosin β4(Tβ4) is necessary and sufficient to induce plasminogen activator inhibitor type 1 (PAI-1) gene expression in endothelial cells. To describe the mechanism of this effect, we produced Tβ4 mutants with impaired functional motifs and tested their intracellular location and activity. Cytoplasmic distributions of Tβ4(AcSDKPT/4A), Tβ4(KLKKTET/7A), and Tβ4(K16A) mutants fused with green fluorescent protein did not differ significantly from those of wild-type Tβ4. Overexpression of Tβ4, Tβ4(AcSDKPT/4A), and Tβ4(K16A) affected intracellular formation of actin filaments. As expected, Tβ4(K16A) uptake by nuclei was impaired. On the other hand, overexpression of Tβ4(KLKKTET/7A) resulted in developing the actin filament network typical of adhering cells, indicating that the mutant lacked the actin binding site. The mechanism by which intracellular Tβ4 induced the PAI-1 gene did not depend upon the N-terminal tetrapeptide AcSDKP and depended only partially on its ability to bind G-actin or enter the nucleus. Both Tβ4 and Tβ4(AcSDKPT/4A) induced the PAI-1 gene to the same extent, whereas mutants Tβ4(KLKKTET/7A) and Tβ4(K16A) retained about 60% of the original activity. By proteomic analysis, the Ku80 subunit of ATP-dependent DNA helicase II was found to be associated with Tβ4. Ku80 and Tβ4 consistently co-immunoprecipitated in a complex from endothelial cells. Co-transfection of endothelial cells with the Ku80 deletion mutants and Tβ4 showed that the C-terminal arm domain of Ku80 is directly involved in this interaction. Furthermore, down-regulation of Ku80 by specific short interference RNA resulted in dramatic reduction in PAI-1 expression at the level of both mRNA and protein synthesis. These data suggest that Ku80 functions as a novel receptor for Tβ4 and mediates its intracellular activity. Thymosin β4(Tβ4) 2The abbreviations used are: Tβ4thymosin β4PAI-1plasminogen activator inhibitor type 1siRNAshort interference RNAHAhemagglutininEGFPenhanced green fluorescent proteinRTreverse transcriptasePBSphosphate-buffered salineMSmass spectroscopyTRITCtetramethylrhodamine isothiocyanateGFPgreen fluorescent protein. is the most abundant member of the highly conserved family of acidic polypeptides called β-thymosins. Although it is a typical intracellular polypeptide, it plays numerous roles, both intracellularly and extracellularly. Numerous observations indicate that Tβ4 is involved in adhesion and spreading of fibroblasts (1Golla R. Philp N. Safer D. Chintapalli J. Hoffman R. Collins L. Nachmias V.T. Cell Motil. Cytoskeleton. 1997; 38: 187-200Crossref PubMed Scopus (45) Google Scholar, 2Kobayashi T. Okada F. Furii N. Tomista N. Ito S. Tazawa H. Aoyama T. Choi S.K. Shibata T. Fujita H. Hosokawa M. Am. J. Pathol. 2002; 160: 869-882Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar), differentiation of endothelial cells (3Grant D.S. Kinsella J.L. Kibbey M.C. LaFlamme S. Burbelo P.D. Goldstein A.L. Kleinman H.K. J. Cell Sci. 1995; 108: 3685-3694Crossref PubMed Google Scholar, 4Grant D.S. Rose W. Yaen C. Goldstein A. Martinez J. Kleinman H. Angiogenesis. 1999; 3: 125-135Crossref PubMed Scopus (123) Google Scholar), directional migration of endothelial cells and keratinocytes (5Malinda K.M. Goldstein A.L. Kleinman H.K. FASEB J. 1997; 11: 474-481Crossref PubMed Scopus (204) Google Scholar, 6Malinda K.M. Sidlu G.S. Mani H. Banaudha K. Maheshwari R.K. Goldstein A.L. Kleinman H.K. J. Investig. Dermatol. 1999; 113: 364-368Abstract Full Text Full Text PDF PubMed Scopus (249) Google Scholar, 7Sosne G. Chan C.C. Tai K. Kennedy M. Soliter E.A. Hazlett L.D. Kleinman H.K. Exp. Eye Res. 2001; 72: 605-608Crossref PubMed Scopus (132) Google Scholar, 8Philp D. Nguyen M. Scheremeta B. St-Surin S. Villa A.M. Orgel A. Kleinman H.K. Elkin M. FASEB J. 2004; 18: 385-387Crossref PubMed Google Scholar), angiogenesis (3Grant D.S. Kinsella J.L. Kibbey M.C. LaFlamme S. Burbelo P.D. Goldstein A.L. Kleinman H.K. J. Cell Sci. 1995; 108: 3685-3694Crossref PubMed Google Scholar, 4Grant D.S. Rose W. Yaen C. Goldstein A. Martinez J. Kleinman H. Angiogenesis. 1999; 3: 125-135Crossref PubMed Scopus (123) Google Scholar, 5Malinda K.M. Goldstein A.L. Kleinman H.K. FASEB J. 1997; 11: 474-481Crossref PubMed Scopus (204) Google Scholar, 6Malinda K.M. Sidlu G.S. Mani H. Banaudha K. Maheshwari R.K. Goldstein A.L. Kleinman H.K. J. Investig. Dermatol. 1999; 113: 364-368Abstract Full Text Full Text PDF PubMed Scopus (249) Google Scholar, 9Koutrafouri V. Leondiadis L. Avgoustakis K. Livaniou E. Czarnecki J. Ithakissios D.S. Evangelatos G.P. Biochim. Biophys. Acta. 2001; 1568: 60-66Crossref PubMed Scopus (79) Google Scholar, 10Cha H.J. Jeong M.J. Kleinman H.K. J. Natl. Cancer Inst. 2003; 95: 1674-1680Crossref PubMed Google Scholar), wound healing (6Malinda K.M. Sidlu G.S. Mani H. Banaudha K. Maheshwari R.K. Goldstein A.L. Kleinman H.K. J. Investig. Dermatol. 1999; 113: 364-368Abstract Full Text Full Text PDF PubMed Scopus (249) Google Scholar, 7Sosne G. Chan C.C. Tai K. Kennedy M. Soliter E.A. Hazlett L.D. Kleinman H.K. Exp. Eye Res. 2001; 72: 605-608Crossref PubMed Scopus (132) Google Scholar, 11Sosne G. Szliter E.A. Barrett R. Kernacki K.A. Kleinman H. Hazlett L.D. Exp. Eye Res. 2002; 74: 293-299Crossref PubMed Scopus (195) Google Scholar), hair follicle growth (8Philp D. Nguyen M. Scheremeta B. St-Surin S. Villa A.M. Orgel A. Kleinman H.K. Elkin M. FASEB J. 2004; 18: 385-387Crossref PubMed Google Scholar), and apoptosis (12Niu M. Nachmias V.T. Cell Commun. Adhes. 2000; 7: 311-312Crossref Scopus (36) Google Scholar, 13Wang W.S. Chen P.M. Hsiao H.L. Wang H.S. Liang W.Y. Su Y. Oncogene. 2004; 23: 6666-6671Crossref PubMed Scopus (102) Google Scholar), and has been described to possess anti-inflammatory properties (11Sosne G. Szliter E.A. Barrett R. Kernacki K.A. Kleinman H. Hazlett L.D. Exp. Eye Res. 2002; 74: 293-299Crossref PubMed Scopus (195) Google Scholar, 14Young J.D. Lawrence A.J. MacLean A.G. Leung B.P. McInnes I.B. Canast B. Pappin D.J. Stevenson R.D. Nat. Med. 1999; 5: 1424-1427Crossref PubMed Scopus (171) Google Scholar). In addition, elevated Tβ4 expression has been observed in various malignant cell lines and tumors (15Hall A.K. Int. J. Cancer. 1991; 48: 672-677Crossref PubMed Scopus (94) Google Scholar, 16Yamamoto T. Gotoh M. Kitajima M. Hirohashi S. Biochem. Biophys. Res. Commun. 1993; 193: 706-710Crossref PubMed Scopus (56) Google Scholar, 17Xie D. Jauch A. Miller C.W. Bartram C.R. Koeffler H.P. Int. J. Oncol. 2002; 21: 499-507PubMed Google Scholar) and its levels seem to be associated with increased tumorigenicity and metastatic potential (10Cha H.J. Jeong M.J. Kleinman H.K. J. Natl. Cancer Inst. 2003; 95: 1674-1680Crossref PubMed Google Scholar, 13Wang W.S. Chen P.M. Hsiao H.L. Wang H.S. Liang W.Y. Su Y. Oncogene. 2004; 23: 6666-6671Crossref PubMed Scopus (102) Google Scholar, 18Clark E.A. Golub T.R. Lander E.S. Hynes R.O. Nature. 2000; 406: 532-535Crossref PubMed Scopus (1309) Google Scholar, 19Dierks H. Kolanus J. Kolanus W. J. Biol. Chem. 2001; 276: 37472-37481Abstract Full Text Full Text PDF PubMed Scopus (34) Google Scholar, 20Ji P. Diederichs S. Wang W. Bing S. Metzger R. Schneider P.M. Tidow N. Brandy B. Buerger H. Bulk E. Thomas M. Berdel W.E. Serve H. Muller-Tidow C. Oncogene. 2003; 22: 8031-8041Crossref PubMed Scopus (1822) Google Scholar). The increased expression of Tβ4 correlates with the invasive capability of the cells, the of and of actin A. M. E. T. A. M.J. E. J. Cell Biol. 2000; PubMed Scopus Google Scholar). increased Tβ4 expression with cell growth W.S. Chen P.M. Hsiao H.L. Wang H.S. Liang W.Y. Su Y. Oncogene. 2004; 23: 6666-6671Crossref PubMed Scopus (102) Google Scholar, W.S. Chen P.M. Hsiao H.L. Su Y. Oncogene. 2003; 22: PubMed Scopus Google Scholar) this not to be T. Okada F. Furii N. Tomista N. Ito S. Tazawa H. Aoyama T. Choi S.K. Shibata T. Fujita H. Hosokawa M. Am. J. Pathol. 2002; 160: 869-882Abstract Full Text Full Text PDF PubMed Scopus (117) Google Scholar, 10Cha H.J. Jeong M.J. Kleinman H.K. J. Natl. Cancer Inst. 2003; 95: 1674-1680Crossref PubMed Google Scholar). thymosin plasminogen activator inhibitor type 1 short interference RNA green fluorescent protein green fluorescent protein. Tβ4 is to be a actin which actin a or by a complex S. J. Biol. Chem. 2001; 276: Full Text Full Text PDF PubMed Scopus Google Scholar). the mechanism by which Tβ4 cell and differentiation is to be with a G-actin and for the of the Tβ4 be found in in and a of the Tβ4 level in to in by the of 2002; PubMed Scopus Google Scholar). observations indicate that Tβ4 its cells Tβ4 to endothelial expression and of plasminogen activator inhibitor type 1 (PAI-1) by the mechanism of the protein to binding to the in the PAI-1 M. R. J. M. A. J. 2004; PubMed Scopus Google Scholar, J. K. E. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google to and in of the and and endothelial cell migration in the A. M. D. Nature. 2004; PubMed Scopus Google Scholar) and and wound healing its on cell and cell D.S. Rose W. Yaen C. Goldstein A. Martinez J. Kleinman H. Angiogenesis. 1999; 3: 125-135Crossref PubMed Scopus (123) Google Scholar, 6Malinda K.M. Sidlu G.S. Mani H. Banaudha K. Maheshwari R.K. Goldstein A.L. Kleinman H.K. J. Investig. Dermatol. 1999; 113: 364-368Abstract Full Text Full Text PDF PubMed Scopus (249) Google Scholar, 11Sosne G. Szliter E.A. Barrett R. Kernacki K.A. Kleinman H. Hazlett L.D. Exp. Eye Res. 2002; 74: 293-299Crossref PubMed Scopus (195) Google Scholar). the which it functions is not Tβ4 by or intracellular or Tβ4 is by cells and its is with G-actin and of the actin filament in we to describe intracellular by which Tβ4 endothelial cells to PAI-1 we for that in endothelial cells with Tβ4 and its on binding and proteomic we the Ku80 subunit of ATP-dependent DNA helicase II to with Tβ4. down-regulation of its expression by short interference RNA the of Tβ4 PAI-1 expression its in PAI-1 gene activity. and from and for of DNA from and from was from and from was from and with and from short interference RNA from other from Cell endothelial cell by of endothelial cells with cell PubMed Google Scholar) was as a from S. of endothelial cell is the D. C. G. Angiogenesis. 2001; PubMed Scopus Google Scholar). The cells in with with and and in a of at of Tβ4 and with Tβ4 was and by and it was and in from and and The was in with and to the of Tβ4 by the by in The mutants Tβ4(AcSDKPT/4A) in which the N-terminal AcSDKP is by this and Tβ4(KLKKTET/7A), the G-actin binding site. mutant was and with a by of and Tβ4 mutants produced a in E. with and to the the or mutants cells with of DNA and of for in of and with of was to cells in of the was by and PAI-1 cells with and used for by the a RNA in and their and by at and for PAI-1 and expression by as we described M. J. J. PubMed Scopus Google Scholar). The and as as and specific for of PAI-1 and gene expression levels the J. P.M. Biochem. 1999; PubMed Scopus Google Scholar). of specific by of Tβ4, and Tβ4 was in E. with cells in binding and on was by for at at a and a to with a The of Tβ4 was by and Tβ4 a at its was with to the To for in endothelial cells, cell and the from cells. To the cell cells with 1 and inhibitor and by for at at of cells as described by J.D. PubMed Scopus Google Scholar), that was used T. M. H. R. E. H. E. J. Biol. Chem. 1995; Full Text Full Text PDF PubMed Scopus Google Scholar). of cells as described by and C. J. 2004; PubMed Scopus Google Scholar) and in 1 and In typical the cell the of or the Tβ4 was and at and the was used as a Tβ4, the same to both and for at The with in for and by by with to the with the of by A. M. M. Chem. PubMed Scopus Google Scholar) and the to with and in to reduction with with and with at for the with of of in and on to a by in the of and directly The was in the of to data in to The protein data was with the The of for was by of the of their in of their and to only highly data of Ku80 and Tβ4 in the Ku80 subunit of ATP-dependent DNA helicase RNA was from cells and The DNA the gene of Ku80 was with the and The was and of the protein the N-terminal mutants of Ku80 as described for the of the Ku80 to its and the and and and and DNA Tβ4 was the and the was and of the protein with at the cells with and or of the mutants and in 1 Cell with of to on a at of was to cell and the for The in and for from the by by and by of the complex from endothelial cell was as described J. K. E. J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar). RNA of the Ku80 gene expression a of the of Ku80 mRNA and the gene as a with the As the functional was for and The of its was to cells with to the of Tβ4 at or at was to cell with the Ku80 gene and to cells. The cells for and with for RNA and protein mRNA for and Ku80 expression was by as described The specific for Ku80 and from cells with Tβ4 and its Ku80 or with to the in and the protein with and with to and The with and by and or was the and and protein by of cells with or its cells on in with with in for with and with with or to actin or Tβ4 was in the cells with specific to Tβ4, by with with The cells a and with intracellular the in the of in of was The of the The has been at of and in and nuclei of the cells was by of a with or a with and In this and used to of from in the same cells. and of cells in a A. Miller J. Biol. Chem. Full Text Full Text PDF PubMed Scopus Google Scholar, Chen R. 2000; PubMed Scopus Google Scholar). of DNA and of for in of was to cells on a in with the was and the cells for the cells with and the of and nuclei was with the and The with fluorescent at and the with the fluorescent at 1 of was and the fluorescent of the cells for at the of and for or for in of the the The cells to Cell and to the of the data for as with and and to the of was of Tβ4 in the of on the mechanism by which Tβ4 angiogenesis we its intracellular in endothelial cells. In the intracellular of Tβ4 and its mutants fused with was by To a functional was to the C-terminal of the The for this was that the C-terminal not of Tβ4. the of Tβ4, which is for with potential to on the of its N-terminal Tβ4 was by of functional motifs with mutants produced that of the N-terminal tetrapeptide AcSDKP the actin binding and with the by the In typical endothelial cells cell with or with the of and with and with or to actin for of the of Tβ4 in to the or Tβ4 by with by with was found in a with a was in to the and was specific was in cells, with and and with the Tβ4 showed expression of the Tβ4. that of the Tβ4, showed in and was to the Tβ4 to Tβ4 with actin at the of cells of Tβ4 and to the at the a and filament in the same cells was at the and of Tβ4 and actin as was at the the the data showed in a indicating of Tβ4 the cell nucleus. the nuclei was a of Tβ4 with the of of that of Tβ4. to the wild-type Tβ4, overexpression of Tβ4(AcSDKPT/4A) affected intracellular formation of actin that be found in the of cells, directly the cell and Tβ4(KLKKTET/7A) and Tβ4(K16A) differ significantly in their from that of the wild-type Tβ4 and their is and not in the In to wild-type Tβ4 and Tβ4(AcSDKPT/4A), cells with Tβ4(KLKKTET/7A) showed a of the actin filament network typical of adhering and cells. that the mutant lacked the actin binding and did not with actin is that of Tβ4 and its mutants in endothelial cells in 1 and was observed in a of cells to by These data indicate that of to the of Tβ4 did not its which is to with To the the of this mutant the cell of cells with or by from to the of the with of the of the was and the of the or its mutant the These data demonstrate significantly of in the cell nuclei with those for To location of Tβ4 and from endothelial cells with or in and and by of the at of at the of both in and of Tβ4(K16A) with wild-type Tβ4 to of Tβ4 and its mutants in endothelial cells we a to specific of and nuclei with and this and of cells. and of Tβ4 and its mutants the with both by and that Tβ4 and its mutants to the their is significantly Tβ4(KLKKTET/7A) and Tβ4(K16A) in in nuclei Tβ4 indicating that their uptake is impaired. of Tβ4 and the we tested increased intracellular levels of Tβ4 or its mutants the by which expression of the PAI-1 gene is this PAI-1 expression was at the level of both mRNA and protein in cells with Tβ4 and its from to expression of PAI-1 mRNA was and the to those that be of cells. that with and resulted in the PAI-1 gene to the same as is by of PAI-1 of the N-terminal tetrapeptide AcSDKP did not the ability of Tβ4 to PAI-1 of the actin binding or of the by a only partially the ability of Tβ4 mutants to PAI-1 tested at the protein as by with by increased intracellular of Tβ4 and its mutants induced PAI-1 expression in cells in the potential which Tβ4 be endothelial cell migration and we for Tβ4 the cells. this the Tβ4 was with in a that of the to the of Tβ4 the of the was and for with To their location in the cells, of or with the Tβ4, and of the was and with the and by of with Tβ4 showed the of a protein with of was consistently found to be to Tβ4 of the the cell cell or the of protein was in the the Tβ4 was with by and to be ATP-dependent DNA helicase its Ku80 subunit In to other of actin to be associated with both of the Tβ4 and the Tβ4. Tβ4 in with Ku80 in endothelial cells. To of we of endothelial cells. with specific to Tβ4, and and by Ku80 to Tβ4 was by specific to Ku80 or in of endothelial cells The from as described The Tβ4 was to the cell the cell or protein the Tβ4 and on of by by of protein to Tβ4 and by as described of the in the protein data of of from the of from the for DNA helicase II DNA helicase II DNA helicase II of the in the protein data of of from the of from the for in a To of the Ku80 binding for Tβ4 and the of this the Ku80 deletion mutants and in As by with specific to cells with showed the same expression of Ku80 or cells with and by the of Ku80 in the as by with that Ku80 the complex with Tβ4 in endothelial cells. that in to only and a complex with Tβ4 and be from endothelial cells with and Ku80 or its that the C-terminal arm domain of Ku80 is directly involved in with Tβ4 and its deletion Tβ4 binding site. To demonstrate the of Ku80 in of PAI-1 in the PAI-1 expression was at the level of both mRNA and protein in cells with or of the mutants and showed in and of cells with or resulted in of PAI-1 expression at the level of both mRNA and protein synthesis. other did not PAI-1 expression in the cells it that binding of Tβ4 to the C-terminal arm domain is not sufficient to PAI-1 expression to it the of the domain of Ku80 by and PAI-1 the of Ku80 on PAI-1 expression in endothelial cells, we specific as a of this protein in cells. this to of Ku80 and their in Ku80 in endothelial cells was and that to Ku80 mRNA and their expression of the protein in endothelial cells to levels of as at the level of both mRNA and protein by and used at the same did not on Ku80 of of Ku80 was cells and PAI-1 expression was tested at the level of mRNA by or protein by and In cells with Tβ4 increased PAI-1 to the level with those observed in the cells of and Tβ4 in the same was not affected both or data that of Ku80 expression resulted in specific of the PAI-1 at the level of its mRNA and PAI-1 synthesis. Furthermore, cells of Ku80 with to a in PAI-1 typical for the cells. data suggest that formation of with Tβ4, is involved in of PAI-1 expression in endothelial cells induced by Tβ4. of showed that Tβ4 functions that for wound and the and of A.L. E. Kleinman H.K. Med. 11: Full Text Full Text PDF PubMed Scopus Google Scholar). to of Tβ4 been the N-terminal AcSDKP C. K. J. D. J.L. E. W. M. PubMed Scopus Google Scholar) and from its domain D. T. E. Kleinman H.K. FASEB J. 2003; PubMed Google Scholar). Although observations that Tβ4 and its by of and of in cell properties necessary for both migration and not is about the by which their The data demonstrate that increased intracellular expression of Tβ4 is necessary and sufficient to PAI-1 gene expression in endothelial cells. is on the expression of Tβ4 in cells to the of the PAI-1 gene by Tβ4. the mechanism of this intracellularly Tβ4 only partially on its ability to bind G-actin or the of other in the Tβ4 as the N-terminal tetrapeptide and the is on the of the N-terminal tetrapeptide with did not on of PAI-1 expression in the cells. of motifs for binding G-actin and the their the ability of mutants to PAI-1 expression in the cells showed in of the PAI-1 Tβ4 and Tβ4(AcSDKPT/4A), showed the same levels of overexpression and a in the cells as by to the at of the of this is the of in endothelial cells, the Ku80 subunit of ATP-dependent DNA helicase which was consistently associated with the Tβ4. Ku80 with Tβ4 cell or as a Ku80 and Tβ4 consistently in a complex from of both endothelial cells and the cells that with Ku80 and Tβ4 fused with Furthermore, with Ku80 deletion mutants showed that Tβ4 directly with the C-terminal arm domain of Ku80 to PAI-1 expression it both the C-terminal arm and the to be in down-regulation of Ku80 expression with in endothelial cells resulted in a dramatic reduction of PAI-1 indicating that Ku80 is involved in by Tβ4 that to of PAI-1 gene expression by a The as by the of with as and T. Y. N. A. M. M. A.J. Natl. Sci. S. A. PubMed Scopus Google Scholar). The and been to and in of DNA DNA and J. Nature. 2001; PubMed Scopus Google Scholar, K. G. G. H. A. E. S. E.A. Biol. 2004; PubMed Scopus Google Scholar, J. C. 2003; PubMed Scopus Google Scholar, A. Chen C. V. M. K. M.C. Nature. PubMed Scopus Google Scholar). is to a in of and cell C. M. G. G. Biochim. Biophys. Acta. Google Scholar). various indicate that as a or Although and be found in the of the showed that in the on the cell and in the C. J. S. B. Cell PubMed Scopus Google Scholar, S. J. S. B. C. J. 2004; 23: PubMed Scopus Google Scholar). is a of the complex in of cells L. D. R. Biochem. Biophys. Res. Commun. 2000; PubMed Scopus Google Scholar) and its expression be induced at it mediates adhesion of cells to S. J. S. B. C. J. 2004; 23: PubMed Scopus Google Scholar, G. M. E.A. Nguyen K.A. D. A. J. Investig. PubMed Google Scholar, Am. J. 2001; PubMed Google Scholar), which its as adhesion receptor M. M. M. F. S. J. Biol. 2004; Scholar). Ku80 was to be a for Y. T. K. J. T. T. Y. Y. T. Scopus Google Scholar). that both Ku80 and L. D. R. Biochem. Biophys. Res. Commun. 2000; PubMed Scopus Google Scholar, T. H. S. M. J. H. S.K. J. 1999; 11: Full Text Full Text PDF PubMed Scopus Google Scholar). Furthermore, with at the cell of highly invasive cells of and cell and at the cell in to by cells of S. J. S. B. C. J. 2004; 23: PubMed Scopus Google Scholar). as and bind in a to W. H. D.J. L. Nature. PubMed Scopus Google Scholar). to the and the of the E.S. Res. 1991; PubMed Scopus Google Scholar), and gene expression J. S. D. C. M. M. C. Biol. 48: Scholar). the mechanism by which Ku80 to PAI-1 gene is been to numerous intracellular that be at the Ku80 at of induced by Tβ4 and to of PAI-1 it is found in it a of Tβ4 and Ku80 has a with data in of Tβ4 the nucleus. Ku80 be a that to the PAI-1 and its To in we that increased intracellular expression of Tβ4 to of the PAI-1 gene in endothelial cells. complex formation with which functions as a novel receptor for Tβ4 and mechanism of the intracellular of Tβ4 from of

References

51